The Enterprise Value as of September 2024 (TTM) for Longeveron Inc. (LGVN) is 18.81M

According to Longeveron Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 18.81M. This represents a change of -12.22% compared to the average of 21.43M of the last 4 quarters.

Longeveron Inc. (LGVN) Historical Enterprise Value (quarterly & annually)

How has LGVN Enterprise Value performed in the past?

The mean historical Enterprise Value of Longeveron Inc. over the last ten years is 296.34M. The current 18.81M Enterprise Value has changed 534.73% with respect to the historical average. Over the past ten years (40 quarters), LGVN's Enterprise Value was at its highest in in the March 2022 quarter at 2.87B. The Enterprise Value was at its lowest in in the June 2024 quarter at -406486.83.

Longeveron Inc. (LGVN) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Longeveron Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Longeveron Inc. (LGVN) Average Enterprise Value

How has LGVN Enterprise Value performed in the past?

The current Enterprise Value of Longeveron Inc. (LGVN) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Longeveron Inc. (LGVN) Enterprise Value vs. Peers

How is LGVN’s Enterprise Value compared to its peers?

Longeveron Inc.’s Enterprise Value is less than Nutriband Inc. (42.46M), greater than Quoin Pharmaceuticals, Ltd. (-339744.00), greater than RenovoRx, Inc. (14.41M), greater than Virax Biolabs Group Limited (8.75M), less than Generation Bio Co. (228.97M), greater than Kronos Bio, Inc. (13.83M), less than Erasca, Inc. (662.29M), less than C4 Therapeutics, Inc. (435.94M), less than Edgewise Therapeutics, Inc. (1.55B), greater than Surrozen, Inc. (-7676046.00), less than Bolt Biotherapeutics, Inc. (37.21M), less than Larimar Therapeutics, Inc. (398.87M), less than Keros Therapeutics, Inc. (1.68B), less than Kezar Life Sciences, Inc. (30.93M), greater than Blue Water Vaccines, Inc. (8.67M), greater than Revelation Biosciences, Inc. (-10569356.00), greater than Hillstream BioPharma, Inc. (1.48M), greater than Kiora Pharmaceuticals, Inc. (4.04M), greater than ABVC BioPharma, Inc. (10.50M), greater than Indaptus Therapeutics, Inc. (8.12M), greater than Pasithea Therapeutics Corp. (-3895653.00), greater than Better Therapeutics, Inc. (7.71M), greater than Forte Biosciences, Inc. (1.13M),

Build a custom stock screener for Longeveron Inc. (LGVN) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Longeveron Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Longeveron Inc. (LGVN) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Longeveron Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.